Menu
Your Cart
20% OFF on all products Shop now

Agalsidase beta

ATC Classification: A16AB04

Agalsidase beta is an enzyme replacement therapy used to treat a rare genetic disorder called Fabry disease. This therapy has numerous benefits for individuals with this condition. By replacing the missing or deficient enzyme, agalsidase beta helps to decrease the accumulation of a certain type of fat in the body. As a result, it alleviates symptoms such as chronic pain, heart problems, and kidney damage. However, it is essential to note that agalsidase beta is not without side effects. Common side effects include fever, headache, and infusion-related reactions. Therefore, proper medical supervision is necessary when using this treatment option. Understanding the intended use and potential side effects of agalsidase beta is crucial for patients and their healthcare providers.

Write a review

Note: HTML is not translated!
Bad Good
   

https://www.medicenter.to/                                                                                                           www.fitbull.to